Quantcast

Latest Oncology Stories

2014-09-25 23:10:54

From September 18 – 21, more than 600 members of the Academy of Oncology Nurse and Patient Navigators (AONN+) gathered in Orlando for the organization’s Fifth Annual Navigation and Survivorship Conference. Highlights of the four-day event included presentations on the hottest topics in navigation, industry updates and networking. Orlando, Fla. (PRWEB) September 25, 2014 Patient navigation is among the fastest growing profession in the healthcare field today, with the average navigator...

2014-09-25 23:09:06

This year, IFA Auto Insurance will continue its tradition of participating in the Making Strides Against Breast Cancer walk, which raises money for breast cancer research and support programs. In addition to joining the walk, which will take place in Edison, New Jersey, on Oct. 26, IFA Auto will be holding various events to help raise money before the event. Edison, NJ (PRWEB) September 25, 2014 IFA Auto Insurance will help raise money for breast cancer research and support programs this...

2014-09-25 23:07:58

On September 26th, the Meso Foundation will participate in a media education program by giving interviews to multiple television and radio stations across the United States to raise awareness of mesothelioma, a cancer best-known for its association with exposure to asbestos. Alexandria, VA (PRWEB) September 25, 2014 The Mesothelioma Applied Research Foundation (Meso Foundation) – a nonprofit organization dedicated to eradicating mesothelioma and easing the suffering caused by the cancer...

2014-09-25 23:02:42

The Firm is evaluating power morcellator lawsuits on behalf of women who allegedly experienced the spread and upstaging of uterine sarcomas and other cancers due to uterine morcellation. New York, New York (PRWEB) September 25, 2014 The controversy surrounding the use of power morcellators (http://www.drugbot.com/morcellator/) shows no signs of abating, as Bernstein Liebhard LLP notes that critics of uterine morcellation are again pushing federal regulators to address the cancer risks...

2014-09-25 23:02:30

The Reproductive Cancer Awareness Month affects both men and women. It is a great reminder to take care of ourselves and to take precaution when it comes to our health. Scotch Plains, NJ (PRWEB) September 25, 2014 September is recognized as “Reproductive Cancer Awareness Month” by many organizations, including the American Cancer Society (http://www.cancer.org/myacs...), in an effort to educate and inform the public. Ovarian and prostate cancer, two of the leading cancers in women...

2014-09-25 23:00:59

The Mesothelioma Applied Research Foundation (Meso Foundation) announced that on September 26th, on Mesothelioma Awareness Day, its volunteers will be raising awareness of mesothelioma by attending the Today show on Rockefeller Plaza in New York. Alexandria, VA (PRWEB) September 25, 2014 The Mesothelioma Applied Research Foundation (Meso Foundation), the national charity dedicated to ending mesothelioma, has announced that for the fifth consecutive year, on Mesothelioma Awareness Day, its...

2014-09-25 08:28:30

SAN DIEGO, Sept. 25, 2014 /PRNewswire/ -- MabVax Therapeutics Holdings, Inc. (OTCQB: TELKD), a clinical stage oncology drug development company, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the Company's vaccine intended for the treatment of the childhood cancer neuroblastoma. In the U.S., the designation carries significant incentives for the development of drugs to treat rare and difficult diseases. The Company is...

2014-09-25 08:26:59

Analyses of PRiDe, a registry of 457 recurrent glioblastoma patients, show that patients treated with the NovoTTF(TM)-100A System at their first and second recurrences had median overall survivals of 20.0 and 8.5 months, respectively ST. HELIER, Jersey, Sept. 25, 2014 /PRNewswire/ -- Novocure, a commercial stage oncology company, announced today that survival and efficacy data from its U.S. patient registry will be presented at the European Society for Medical Oncology (ESMO) Meeting...

2014-09-25 04:22:01

LUGANO, Switzerland, September 25, 2014 /PRNewswire/ -- Helsinn Group, a company focused on building quality cancer care, today announces that Phase III data from the largest trial program of its kind to date in anamorelin, a novel, once-daily ghrelin receptor agonist in development for cancer-anorexia-cachexia (CACS) in non-small cell lung cancer will be presented at the 38th European Society for Medical Oncology (ESMO) Congress in Madrid, Spain, in 2014. Cancer...

2014-09-24 23:12:26

In CHAMPS Oncology's most recent blog post, Clarifications to CoC Ch. 3 Phase In Standards for 2015, Ilona Gyerman shares her thoughts on the topic. Cleveland, Ohio (PRWEB) September 24, 2014 In CHAMPS Oncology's most recent blog post, Clarifications to CoC Ch. 3 Phase In Standards for 2015, Ilona Gyerman shares her thoughts on the topic. The Commission on Cancer (CoC) recently communicated clarifications to their 2015 Chapter 3 phase-in standards in two CoC Source special...


Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related